BACKGROUND: Nitrogen dioxide (NO(2)) and environmental tobacco smoke (ETS) have been associated with adverse respiratory effects. OBJECTIVE: We sought to assess the effect of NO(2) and ETS on asthma morbidity among children in inner-city environments. METHODS: Asthmatic children between the ages of 4 and 9 years had exposure to NO(2) and ETS measured by using Palmes tubes in the home and urinary cotinine. A baseline interview and telephone assessments at 3, 6, and 9 months evaluated health service use, asthma symptoms, and peak flow rates. RESULTS: Gas stoves were present in 87.8% of 469 homes. The median level of indoor NO(2) was 29.8 ppb compared with the US national outdoor median of 18 ppb. Of 1444 children, 48% had urinary cotinine/creatinine ratios of greater than 30 ng/mg. The median level of the cotinine/creatinine ratio was 42.4 ng/mg in smoking homes compared with 18.0 ng/mg in nonsmoking homes. The relative risk for asthma symptoms with increased NO(2) exposure was 1.75 (95% CI, 1.10-2.78) in children who did not have positive skin test responses. Higher NO(2) exposure resulted in lower peak flows during colder months (relative risk, 1.46; 95% CI, 1.07-1.97). Higher ETS exposure in colder months was weakly associated with lower peak flows (relative risk, 1.21; 95% CI, 0.99-1.47). There was no effect of ETS exposure on symptoms or use of health care services. CONCLUSION: Higher levels of indoor NO(2) are associated with increased asthma symptoms in nonatopic children and decreased peak flows. CLINICAL IMPLICATIONS: Interventions to reduce NO(2) exposure, such as venting of gas stoves, might help reduce asthma morbidity.
BACKGROUND:Nitrogen dioxide (NO(2)) and environmental tobacco smoke (ETS) have been associated with adverse respiratory effects. OBJECTIVE: We sought to assess the effect of NO(2) and ETS on asthma morbidity among children in inner-city environments. METHODS: Asthmatic children between the ages of 4 and 9 years had exposure to NO(2) and ETS measured by using Palmes tubes in the home and urinary cotinine. A baseline interview and telephone assessments at 3, 6, and 9 months evaluated health service use, asthma symptoms, and peak flow rates. RESULTS: Gas stoves were present in 87.8% of 469 homes. The median level of indoor NO(2) was 29.8 ppb compared with the US national outdoor median of 18 ppb. Of 1444 children, 48% had urinary cotinine/creatinine ratios of greater than 30 ng/mg. The median level of the cotinine/creatinine ratio was 42.4 ng/mg in smoking homes compared with 18.0 ng/mg in nonsmoking homes. The relative risk for asthma symptoms with increased NO(2) exposure was 1.75 (95% CI, 1.10-2.78) in children who did not have positive skin test responses. Higher NO(2) exposure resulted in lower peak flows during colder months (relative risk, 1.46; 95% CI, 1.07-1.97). Higher ETS exposure in colder months was weakly associated with lower peak flows (relative risk, 1.21; 95% CI, 0.99-1.47). There was no effect of ETS exposure on symptoms or use of health care services. CONCLUSION: Higher levels of indoor NO(2) are associated with increased asthma symptoms in nonatopic children and decreased peak flows. CLINICAL IMPLICATIONS: Interventions to reduce NO(2) exposure, such as venting of gas stoves, might help reduce asthma morbidity.
Authors: Robin S Everhart; Sheryl Kopel; Elizabeth L McQuaid; Leslie Salcedo; Daniel York; Christina Potter; Daphne Koinis-Mitchell Journal: Pediatr Allergy Immunol Pulmonol Date: 2011-09 Impact factor: 1.349
Authors: Patrick N Breysse; Gregory B Diette; Elizabeth C Matsui; Arlene M Butz; Nadia N Hansel; Meredith C McCormack Journal: Proc Am Thorac Soc Date: 2010-05
Authors: Rima Habre; Brent Coull; Erin Moshier; James Godbold; Avi Grunin; Amit Nath; William Castro; Neil Schachter; Annette Rohr; Meyer Kattan; John Spengler; Petros Koutrakis Journal: J Expo Sci Environ Epidemiol Date: 2013-10-30 Impact factor: 5.563
Authors: Robin S Everhart; Sheryl J Kopel; Cynthia A Esteban; Elizabeth L McQuaid; Robert Klein; Christine E McCue; Daphne Koinis-Mitchell Journal: Ann Allergy Asthma Immunol Date: 2014-02-28 Impact factor: 6.347
Authors: Samantha R Hodgkins; Jennifer L Ather; Sara A Paveglio; Jenna L Allard; Laurie A Whittaker LeClair; Benjamin T Suratt; Jonathan E Boyson; Matthew E Poynter Journal: Respir Res Date: 2010-07-26
Authors: C K Jennifer Loo; Richard G Foty; Amanda J Wheeler; J David Miller; Greg Evans; David M Stieb; Sharon D Dell Journal: Int J Environ Res Public Health Date: 2010-08-23 Impact factor: 3.390
Authors: Kathleen Belanger; Theodore R Holford; Janneane F Gent; Melissa E Hill; Julie M Kezik; Brian P Leaderer Journal: Epidemiology Date: 2013-03 Impact factor: 4.822